The mission of the Oxford Centre for Cancer Early Detection and Prevention (OxCODE) Travel Award is to raise the profile of Oxford’s early detection and precision prevention research by competitively funding the attendance of early career researchers (students and post-doctoral researchers, or equivalent) at two major annual cancer prevention and early detection conferences.
The Cancer Prevention Research conference is an new annual conference hosted by the American Cancer Society and Cancer Research UK, which runs this year in London from 25-27th June. The Early Detection of Cancer conference runs this year from 21st-23rd October in Portland, USA.
After peer review by the OxCODE Operational Group, funds were allocated to the following people:
- Dr Zinaida Dedeic (Bladgen group, Department of Oncology) “LungVax: A Precision Prevention approach to vaccinate against lung cancer in an at-risk population”
- Joshua Fieggen (Clifton group, Institute of Biomedical Engineering) “Dysregulated Immune Proteins in Plasma in the UK Biobank Predict Multiple Myeloma 12 years Before Clinical Diagnosis”
- Ella Mi (Song group, Ludwig Institute for Cancer Research) “Multimodal cell free DNA epigenetic sequencing for early detection of pancreatic cancer”
- Shizhe Xu (Kartsonaki group, Oxford Population Health) “Unraveling Breast Cancer Genetic Risk in Chinese Women: Integrating GWAS, Fine-Mapping, and Machine Learning in the China Kadoorie Biobank”
- Yuhan Zheng (Papiez group, Big Data Institute) “Advancing Esophageal Cancer Management with Machine Learning: Multicentre Survival Prediction Models and Novel Insights”
- Dr Noushin Zibandeh (Bottomley group, CAMS Oxford Institute) “Circulating T cell immunosenescence is poorly reflected amongst Tissue-resident T cells in healthy skin: preliminary findings from a clinical study”
Congratulations to these awardees and thank you to all applicants for their submissions.